Follow
Fereshteh Fallah Atanaki
Fereshteh Fallah Atanaki
PhD Student of Bioinformatics, Tehran University
Verified email at ut.ac.ir
Title
Cited by
Cited by
Year
IAMPE: NMR-assisted computational prediction of antimicrobial peptides
K Kavousi, M Bagheri, S Behrouzi, S Vafadar, FF Atanaki, BT Lotfabadi, ...
Journal of Chemical Information and Modeling 60 (10), 4691-4701, 2020
182020
miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines
E Arefian, F Fallah Atanaki, K Kavousi, M Soleimani
Scientific reports 10 (1), 1-12, 2020
172020
BIPEP: Sequence-based prediction of biofilm inhibitory peptides using a combination of nmr and physicochemical descriptors
F Fallah Atanaki, S Behrouzi, S Ariaeenejad, A Boroomand, K Kavousi
ACS omega 5 (13), 7290-7297, 2020
142020
MCIC: automated identification of cellulases from metagenomic data and characterization based on temperature and pH dependence
M Foroozandeh Shahraki, S Ariaeenejad, F Fallah Atanaki, B Zolfaghari, ...
Frontiers in microbiology, 2646, 2020
102020
Co-abundance analysis reveals hidden players associated with high methane yield phenotype in sheep rumen microbiome
L Ghanbari Maman, F Palizban, F Fallah Atanaki, N Elmi Ghiasi, ...
Scientific Reports 10 (1), 1-12, 2020
82020
CpACpP: In Silico Cell-Penetrating Anticancer Peptide Prediction Using a Novel Bioinformatics Framework
F Nasiri, FF Atanaki, S Behrouzi, K Kavousi, M Bagheri
ACS omega 6 (30), 19846-19859, 2021
22021
A computational learning paradigm to targeted discovery of biocatalysts from metagenomic data: A case study of lipase identification
MF Shahraki, FF Atanaki, S Ariaeenejad, MR Ghaffari, ...
Biotechnology and Bioengineering 119 (4), 1115-1128, 2022
12022
The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway
F Gheidari, E Arefian, FJ Adegani, FF Atanaki, M Soleimani
Iranian Journal of Pharmaceutical Research: IJPR 20 (4), 202, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–8